Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2008-04-02 | Reverse | 647:2000 |
MiMedx Group, Inc. develops and distributes patented placental tissue allografts for wound care, surgical recovery, burns, sports medicine, and dental applications primarily in the U.S.

MiMedx's flagship dHACM allograft is a proven, insurance-covered barrier that promotes healing in acute and chronic wounds, exemplifying their focus on advanced wound care.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Surgical | $36.63M | $39.42M ▲ | $36.37M ▼ | $39.3M ▲ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
DNTH | $110.16 | COMPARE |
ATAI | $7.34 | COMPARE |
RAPP | $46.34 | COMPARE |
NKTR | $76.52 | COMPARE |
SNDX | $20.31 | COMPARE |
TSHA | $5.49 | COMPARE |
INBX | $112.60 | COMPARE |
INVA | $21.41 | COMPARE |